 Connection
Scott Auerbach to Cohort Studies
This is a "connection" page, showing publications Scott Auerbach has written about Cohort Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.148 |
|
|
|
-
James KA, Gralla J, Ridall LA, Do TN, Czaja AS, Mourani PM, Ciafaloni E, Cunniff C, Donnelly J, Oleszek J, Pandya S, Price E, Yang ML, Auerbach SR. Left ventricular dysfunction in Duchenne muscular dystrophy. Cardiol Young. 2020 Feb; 30(2):171-176.
Score: 0.087
-
Conway J, Auerbach SR, Richmond ME, Sharp B, Pahl E, Feingold B, Azeka E, Dryer WJ, Cantor RS, Kirklin JK. Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients. J Heart Lung Transplant. 2022 03; 41(3):327-333.
Score: 0.025
-
Rager JE, Auerbach SS, Chappell GA, Martin E, Thompson CM, Fry RC. Benchmark Dose Modeling Estimates of the Concentrations of Inorganic Arsenic That Induce Changes to the Neonatal Transcriptome, Proteome, and Epigenome in a Pregnancy Cohort. Chem Res Toxicol. 2017 10 16; 30(10):1911-1920.
Score: 0.019
-
Almond CS, Hoen H, Rossano JW, Castleberry C, Auerbach SR, Yang L, Lal AK, Everitt MD, Fenton M, Hollander SA, Pahl E, Pruitt E, Rosenthal DN, McElhinney DB, Daly KP, Desai M. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2018 04; 37(4):441-450.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|